CL
BMY.RT

CSS LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CSS LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-559,562
Closed -$387K – 1250
2020
Q4 		$387K Buy
559,562
+121,755
+28% +$259K 0.01% 515
2020
Q3 		$983K Buy
437,807
+50,000
+13% +$143K 0.05% 297
2020
Q2 		$1.39M Sell
387,807
-400
-0.1% -$1.44K 0.08% 213
2020
Q1 		$1.48M Buy
388,207
+27,700
+8% +$91.2K 0.12% 161
2019
Q4 		$1.08M Buy
+360,507
New +$937K 0.06% 238

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CSS LLC's BMY.RT Position: Q1 2021 in Review

CSS LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 559,562 shares — an estimated $387K sold.

CSS LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.48M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • CSS LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • CSS LLC sold 559,562 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $387K.
  • CSS LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • CSS LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.48M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.